Skip to Content
Radiation Research Program
Contact NExT
Show menu
Search this site
Last Updated: 04/23/24

Funding Opportunities

RRP Initiatives (current)

FOA # Initiative Title
NOT-EB-23-022 Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications
NOT-EY-23-009 Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)
PAR-22-198 Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
PAR-22-199 Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
PAR-22-139 Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
PAR-22-140 Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

RRP Initiatives (expired)

FOA # Initiative Title
NOT-CA-24-015 Notice of Special Interest (NOSI): Administrative Supplements to Support the Development of Digital Twins in Radiation Oncology (DTRO)
NOT-CA-23-059 Notice of Special Interest (NOSI): Administrative Supplements for the Dog Oncology Grant Supplement (DOGS) Program
RFA-CA-22-046 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
NOT-CA-22-113 Notice of Intent to Publish a Funding Opportunity Announcement for Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
RFA-CA-21-052 Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed)
RFA-CA-21-053 Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)
RFA-CA-21-040 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
RFA-CA-20-032 Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)
PAR-CA-16-111 Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)

Other NCI & NIH Relevant Initiatives

FOA # Initiative Title
RFA-CA-19-049 Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed); Note: applications that explore mechanisms of resistance to radiation and combined modalities are encouraged. Note: this FOA has expired.
RFA-CA-19-050 Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed) Note: this FOA has expired.
RFA-CA-19-052 Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed) Note: this FOA has expired.